-
알렉스 보디와 남수단 공화국의 굼 도미니크 마티오크 대사, 베를린에서 부쿠레슈티 명예영사관 설치 가능성 논의
-
亞歷克斯・博迪與南蘇丹共和國大使古姆・多米尼克・馬蒂奧克在柏林商討於布加勒斯特設立名譽領事館的可能性
-
Russia strikes hit Kyiv as Germany's Merz visits
-
АЛЕКС БОДІ ТА ПОСОЛ РЕСПУБЛІКИ ПІВДЕННИЙ СУДАН ГУМ ДОМІНІК МАТІОК ОБГОВОРЮЮТЬ У БЕРЛІНІ МОЖЛИВІСТЬ ВІДКРИТТЯ ПОЧЕСНОГО КОНСУЛЬСТВА В БУХАРЕСТІ
-
South Korea captain 'deeply sorry' for gloating about military exemption
-
Germany's Merz in Kyiv for talks with Zelensky
-
Alcaraz through to Japan Open semis after Shapovalov injury
-
Asian Games set to close after records, rancour and rain
-
Chanel: unpicking one year of 'Blazymania'
-
Cry for help as French-Swiss lake dries up
-
Latvian pro-Europeans set for election win: partial results
-
Sabalenka swept out of China Open in third round
-
China swim sensation Yu Zidi, 13, says 'I'm no prodigy'
-
US urges 'restraint' as Ethiopia's Tigray crisis rocks region
-
Yu Zidi to Ohashi: Asian Games stars who can light up LA Olympics
-
Teens on target again as USA down Mexico 3-0
-
'Act before it's too late': Tokyo residents fight for more trees
-
World records prove Asian Games were a hit, says top official
-
'Disappointing' as South Korea flag mishap sees Games end on sour note
-
US prison chief who oversaw botched execution resigns
-
Pre-COP host Tuvalu at frontline of climate change
-
'Chaotic' Asian Games threaten Japan hopes of hosting Olympics again
-
Hungary's dwindling paprika producers battle to save signature spice
-
Finnish town braces for change from Google data centres
-
Cornell president vows review in wake of alleged student gang rape
-
What is fuelling French school protests?
-
Latvian partial election results suggest pro-European choice
-
Without lawyers, migrant children face deportation from the US
-
In Egypt's Sinai, Gazan builds school for children displaced by war
-
Three-peat seeking Dodgers open playoffs with a win, Rays hold off Yankees
-
Trump tariffs a mixed bag for US auto industry
-
Brazil votes in nail-biter polls closely watched by Trump
-
Yemen government forces say struck Houthi targets
-
'Just be you': Kim reveals Tiger text that inspired him to gold
-
Music links past, present for Pedro Pascal's cellist in 'Behemoth!'
-
Myanmar migrants returned to war-torn nation from Malaysia
-
ALEX BODI ȘI AMBASADORUL REPUBLICII SUDANUL DE SUD, GUM DOMINIC MATIOK, DISCUTĂ LA BERLIN DESPRE POSIBILITATEA ÎNFIINȚĂRII UNUI CONSULAT ONORIFIC LA BUCUREȘTI
-
ALEX BODI AND AMBASSADOR GUM DOMINIC MATIOK OF THE REPUBLIC OF SOUTH SUDAN MEET IN BERLIN TO DISCUSS THE POSSIBILITY OF AN HONORARY CONSULATE IN BUCHAREST
-
Dodgers step up World Series three-peat bid with 5-3 win over Braves
-
Lula, Bolsonaro wrap up campaigns ahead of Brazil's knife-edge vote
-
Spain break down Czechs as England outclass Croatia in Nations League
-
Toulouse edge Castres in Top 14 derby
-
Yamal on target as Spain hold off Czech Republic
-
Murakami homer propels White Sox to MLB playoff win over Guardians
-
Latvian exit polls suggest pro-European choice
-
Israel targets top Hamas leader in deadly Gaza strike on anniversary
-
Lula, Bolsonaro wrap up campaigns ahead of knife-edge election
-
Houthis say struck oil facility near Riyadh, as Saudis hit Sanaa
-
Tuchel hails 'complete' England after Croatia demolition
-
AI needs safety layers like nuclear plants: ex-OpenAI engineer
Biden calls for lower prices of Ozempic, similar drugs
US President Joe Biden on Tuesday called on pharmaceutical giants Novo Nordisk and Eli Lilly to lower prices for diabetes and weight loss drugs such as Ozempic, saying firms must stop "ripping off the American people."
In an article written with Senator Bernie Sanders, Biden said US patients pay several times more than in Canada, Germany and Denmark for Nordisk's diabetes drugs Ozempic and Wegovy, which can also be used for weight loss.
One-month supply of Ozempic in the United States last year was $936, compared to $169 in Canada and $103 in Germany, according to one study.
Eli Lilly was also charging "unconscionably high prices" for Mounjaro, a drug similar to Ozempic.
"Why should people in Burlington, Vermont, pay so much more than people in Copenhagen or Berlin for the same drug?" wrote Biden and Sanders, who chairs the Senate healthcare committee.
Such "price gouging" makes the drugs unaffordable to millions of Americans, they said.
"If the prices of these drugs are not substantially reduced, they have the potential to bankrupt the American health care system," Biden and Sanders wrote. "We will not allow that to happen."
Nordisk and Lilly did not immediately respond to an AFP request for comment.
High prices for prescription drugs have been a long-standing problem for American patients, and Democrat Biden has focused on lowering healthcare costs as part of his reelection campaign in November.
The piece in USA Today comes days after Biden's weak performance during a televised presidential debate with Republican Donald Trump sparked sharp concern among Democrats.
M.Fischer--AMWN